Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TE TechCrunch 
Key takeaways
Science Corporation implanted its PRIMA vision-restoring chip in a Stargardt disease patient, marking a milestone in its BCI research.
- PRIMA is a retinal prosthesis designed to restore vision by stimulating the optic nerve.
- Stargardt disease causes central vision loss and is currently incurable.
- The company aims to expand BCIs into various medical applications beyond controlling computers.
Summarised automatically by AI from the original article by TechCrunch. AI can make mistakes, so check the original for details.
Read the full story on TechCrunch You've read the opening, about 32 of 856 words. The full piece is published by TechCrunch.
Continue reading ↗ Story details
- Published
- By
- Aisha Malik
- Section
- AI
- Length
- 856 words · about 4 min read
- Format
- Article
- Original
- techcrunch.com ↗
Topics
